Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2079 of 6351
-
Keytruda takes on rare chest cancers: early trial launches
Disease control Recruiting nowThis phase I trial studies the sides effects and best dose of pembrolizumab in treating participants with thymoma or thymic cancer that cannot be removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the canc…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Scientists hunt for clues to predict rare brain disease before symptoms strike
Knowledge-focused Recruiting nowWe are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Wireless lung sensor could keep heart failure patients out of hospital
Disease control CompletedThis is a prospective, multi-center, open-label, single-arm feasibility trial to assess device safety and efficacy of the Cordella™ Heart Failure System in 10 NYHA Class III heart failure patients who will receive the Cordella™ Sensor implant.
Sponsor: Endotronix, Inc. • Aim: Disease control
Last updated Jun 26, 2026 12:49 UTC
-
Scientists test Lab-Made corneal implants to restore sight
Disease control Recruiting nowAssessment of safety and efficacy of tissue-engineered corneal endothelial graft material generated using cultured human corneal endothelial cells for tissue-engineered endothelial keratoplasty (TE-EK).
Phase 1 • Sponsor: Singapore Eye Research Institute • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC
-
Alzheimer's drug TRx0237 put to the test in large trial
Disease control CompletedThe purpose of this study is to determine the safety and efficacy of TRx0237 16 mg/day and 8 mg/day in the treatment of subjects with Alzheimer's Disease compared to placebo. In addition, an open-label, delayed-start phase is included to demonstrate a disease-modifying effect of …
Phase 3 • Sponsor: TauRx Therapeutics Ltd • Aim: Disease control
Last updated Jun 26, 2026 13:28 UTC
-
Painless spinal zaps may restore hand movement after paralysis
Symptom relief CompletedStimulation of the spinal cord may induce the growth and reorganization of neural pathways leading to the re-animation of paralyzed limbs. Growing evidence indicates that electrical spinal cord stimulation improves motor functions immediately via modulating the excitability of sp…
Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Experimental combo shows promise for rare sarcomas
Disease control CompletedSoft tissue sarcomas (STS) are a group of rare mesenchymal neoplasms affecting all ages. STS most commonly present as localised disease but despite surgery and adjuvant treatment more than half of patients will develop recurrent or metastatic disease. Leiomyosarcoma (LMS), a mali…
Phase 1/2 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug may lessen painful side effects of anal cancer therapy
Disease control OngoingOver 80% of anal cancers are squamous cell carcinoma (SCC). Current standard treatment for locally advanced squamous cell carcinoma of the anal canal is a combination of radiation therapy (RT) and concurrent chemotherapy. This allows for organ preservation in approximately 75% of…
Phase 1/2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Arm cuff procedure tested to fight organ failure in septic shock
Disease control CompletedSeptic shock remains a major public health problem in industrialized countries, with a mortality rate as high as 50%, largely related to multiple organ dysfunction. In addition to dysregulated inflammatory response, the pathophysiology of organ failures in septic shock involves i…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug targets tough childhood cancers with genetic flaws
Disease control CompletedThis phase II Pediatric MATCH trial studies how well samotolisib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with TSC or PI3K/MTOR mutations that have spread to other places in the body (metastatic) and have come back (recurrent) o…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Immunotherapy combo shows promise in cervical cancer trial
Disease control CompletedTo date, the majority of clinical trials on checkpoint inhibitors have tested these agents as monotherapy, and the next logical step is to evaluate rational therapeutic associations. The aim of the NiCOL study is to assess the safety of nivolumab in association with chemoradiatio…
Phase 1/2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 26, 2026 19:18 UTC
-
Can a cancer drug stop myeloma before it starts?
Disease control OngoingThis research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple Myeloma (SMM). The drug involved in this study is: -Daratumumab
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a less invasive surgery speed up pilon fracture healing?
Disease control Stopped earlyThe assessment consists in comparing the osteosynthesis plate with minimally invasive technique versus open reduction and internal fixation. The aim of study is to compare (period of bandage, efficacy, safety), these two types of surgical technique by using a prospective, random…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New chemo cocktail aims to make stem cell transplants safer for seniors
Disease control OngoingThis study is testing a combination of chemo-immuno therapy called RBM. RBM consists of combination of drugs: rituximab, bendamustine, and melphalan followed by reinfusion of the participants own stem cells which is called autologous stem cell transplant (ASCT). Compared to the s…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Can PrEP stop HIV in west african men? new study says yes, it's feasible.
Prevention CompletedThis demonstration project will assess the acceptability and feasibility of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) as part of a comprehensive HIV prevention package in community-based clinics in West Africa. An interventional, open label, multidiscip…
Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo shows promise for tough cancers
Disease control CompletedThis is a modular, Phase I/II, multicentre study to investigate CT7001 monotherapy in advanced solid malignancies and to further investigate CT7001 as monotherapy or in combination with standard therapy in specific participant groups with Triple Negative Breast Cancer (TNBC), Cas…
Phase 1/2 • Sponsor: Carrick Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail aims to keep multiple myeloma in check
Disease control Stopped earlyThe main aim is to evaluate the effect of Ixazomib in combination with lenalidomide and dexamethasone on Multiple Myeloma disease progression at 2 years in participants who previously received a bortezomib-based induction regimen. The study will enroll approximately 160 particip…
Phase 4 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Immunotherapy drug shows promise for tough brain tumor
Disease control OngoingThis research study is studying a drug as a possible treatment for High Grade Meningioma. The drug involved in this study is an immunotherapy drug called pembrolizumab
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Bionic implant shows promise for restoring sight in dry AMD
Disease control CompletedIn this study, the principle functionality of the device will be tested in humans for the first time. The study will evaluate the extent to which patients with atrophic dry age related macular degeneration (AMD) have evoked light perception using the implant.
Sponsor: Science Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug combo shows promise for Tough-to-Treat uterine cancer
Disease control OngoingThis is a phase 2 study of investigational drug niraparib and TSR-042 in patients with advanced/recurrent endometrial cancer. The purpose of this study is to determine whether blocking a protein called poly (ADP-ribose) polymerase (PARP) with niraparib provides clinical benefit i…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC